Jörg Kaufmann

4.6k total citations
63 papers, 3.3k citations indexed

About

Jörg Kaufmann is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Jörg Kaufmann has authored 63 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Rheumatology and 9 papers in Cancer Research. Recurrent topics in Jörg Kaufmann's work include Rheumatoid Arthritis Research and Therapies (12 papers), RNA Interference and Gene Delivery (9 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Jörg Kaufmann is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), RNA Interference and Gene Delivery (9 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Jörg Kaufmann collaborates with scholars based in Germany, United States and Switzerland. Jörg Kaufmann's co-authors include Ansgar Santel, Stephen T. Smale, Klaus Giese, Oliver Keil, Anke Klippel, Rolf Schwarzer, Daniel Tondera, W. Arnold, Manuela Aleku and Sibylle Dames and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Jörg Kaufmann

63 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Kaufmann Germany 30 2.0k 581 509 372 301 63 3.3k
Irma Dianzani Italy 35 3.4k 1.7× 377 0.6× 690 1.4× 655 1.8× 267 0.9× 142 5.0k
Michel Simon France 44 1.7k 0.9× 1.4k 2.4× 387 0.8× 1.1k 2.9× 336 1.1× 142 5.9k
Pauline M. Chou United States 31 1.2k 0.6× 399 0.7× 503 1.0× 191 0.5× 325 1.1× 98 3.1k
Andrew E. Parker United Kingdom 23 1.3k 0.6× 417 0.7× 513 1.0× 900 2.4× 187 0.6× 36 2.8k
Pedro López‐Romero Spain 24 1.0k 0.5× 224 0.4× 494 1.0× 236 0.6× 141 0.5× 49 2.4k
Gary Warnes United Kingdom 20 1.6k 0.8× 274 0.5× 186 0.4× 1.1k 2.8× 263 0.9× 42 3.3k
Alan D. Proia United States 35 976 0.5× 262 0.5× 258 0.5× 463 1.2× 320 1.1× 163 3.6k
Anita C. Gilliam United States 30 1.5k 0.8× 200 0.3× 185 0.4× 854 2.3× 382 1.3× 66 3.6k
T. Nukiwa Japan 30 1.0k 0.5× 214 0.4× 728 1.4× 271 0.7× 344 1.1× 76 3.8k

Countries citing papers authored by Jörg Kaufmann

Since Specialization
Citations

This map shows the geographic impact of Jörg Kaufmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Kaufmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Kaufmann more than expected).

Fields of papers citing papers by Jörg Kaufmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Kaufmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Kaufmann. The network helps show where Jörg Kaufmann may publish in the future.

Co-authorship network of co-authors of Jörg Kaufmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Kaufmann. A scholar is included among the top collaborators of Jörg Kaufmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Kaufmann. Jörg Kaufmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Radloff, Katrin, Birgitt Gutbier, Hanieh Moradian, et al.. (2023). Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage. Molecular Therapy — Nucleic Acids. 34. 102068–102068. 8 indexed citations
2.
Gutbier, Birgitt, Katrin Reppe, Ansgar Santel, et al.. (2018). Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia. American Journal of Respiratory and Critical Care Medicine. 198(2). 220–231. 46 indexed citations
3.
4.
Zink, A., Bernhard Manger, Jörg Kaufmann, et al.. (2013). Evaluation of the RABBIT Risk Score for serious infections. Annals of the Rheumatic Diseases. 73(9). 1673–1676. 86 indexed citations
5.
Strumberg, Dirk, Beate Schultheis, Christiane Vank, et al.. (2011). Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors. International Journal of Clinical Pharmacology and Therapeutics. 50(1). 76–78. 112 indexed citations
6.
Santel, Ansgar, Manuela Aleku, Nadine Röder, et al.. (2010). Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis Models. Clinical Cancer Research. 16(22). 5469–5480. 81 indexed citations
7.
Kaufmann, Jörg, Katharina Ahrens, & Ansgar Santel. (2010). RNA interference for therapy in the vascular endothelium. Microvascular Research. 80(2). 286–293. 12 indexed citations
8.
Backhaus, M., Sarah Ohrndorf, H. Kellner, et al.. (2009). Evaluation of a novel 7‐joint ultrasound score in daily rheumatologic practice: A pilot project. Arthritis Care & Research. 61(9). 1194–1201. 318 indexed citations
9.
Möpert, Kristin, et al.. (2009). Loss of Drp1 function alters OPA1 processing and changes mitochondrial membrane organization. Experimental Cell Research. 315(13). 2165–2180. 57 indexed citations
10.
Schwarzer, Rolf, Daniel Tondera, W. Arnold, et al.. (2004). REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase. Oncogene. 24(7). 1138–1149. 111 indexed citations
11.
Tondera, Daniel, Ansgar Santel, Rolf Schwarzer, et al.. (2004). Knockdown of MTP18, a Novel Phosphatidylinositol 3-Kinase-dependent Protein, Affects Mitochondrial Morphology and Induces Apoptosis. Journal of Biological Chemistry. 279(30). 31544–31555. 123 indexed citations
12.
Giese, Klaus, Jörg Kaufmann, Gijsbertus J. Pronk, & Anke Klippel. (2002). Unravelling novel intracellular pathways in cell-based assays. Drug Discovery Today. 7(3). 179–186. 24 indexed citations
13.
Kaufmann, Jörg, et al.. (1998). CIF150, a Human Cofactor for Transcription Factor IID-Dependent Initiator Function. Molecular and Cellular Biology. 18(1). 233–239. 54 indexed citations
14.
Smale, Stephen T., Abhinav K. Jain, Jörg Kaufmann, et al.. (1998). The Initiator Element: A Paradigm for Core Promoter Heterogeneity within Metazoan Protein-coding Genes. Cold Spring Harbor Symposia on Quantitative Biology. 63(0). 21–32. 81 indexed citations
15.
Kaufmann, Jörg, et al.. (1998). Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. Journal of Clinical Laboratory Analysis. 12(3). 137–144. 136 indexed citations
16.
Klinger, G, et al.. (1995). The influence of Microgynon® and Diane-35®, two sub-fifty ovulation inhibitors, on voice function in women. Contraception. 52(6). 343–348. 17 indexed citations
17.
Kaufmann, Jörg & Albrecht Klein. (1992). Gene dosage as a possible major determinant for equal expression levels of genes encoding RNA polymerase subunits in the hypotrichous ciliateEuplotes octocarinatus. Nucleic Acids Research. 20(17). 4445–4450. 22 indexed citations
18.
19.
Aydınlık, S., et al.. (1990). Long-term therapy of signs of androgenisation with a low-dosed antiandrogen-oestrogen combination.. Clinical Trials. 27(6). 14 indexed citations
20.
Nickisch, Klaus, et al.. (1989). Effects of Topically Applied Antiandrogenic Compounds on Sebaceous Glands of Hamster Ears and Flank Organs.. Journal of Investigative Dermatology. 92(5). 769–773. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irma Dianzani Breakdown of academic impact, for papers by Michel Simon Breakdown of academic impact, for papers by Pauline M. Chou Breakdown of academic impact, for papers by Andrew E. Parker Breakdown of academic impact, for papers by Pedro López‐Romero Breakdown of academic impact, for papers by Gary Warnes Breakdown of academic impact, for papers by Alan D. Proia Breakdown of academic impact, for papers by Anita C. Gilliam Breakdown of academic impact, for papers by T. Nukiwa
Rankless by CCL
2026